JAN 07, 2017 8:28 AM PST

How a Native Indian Pepper Suppresses Cancer

WRITTEN BY: Xuan Pham

Peppers are in the spotlight again this week as scientists reveal the biological mechanism behind the anticancer effects of a different compound from an Indian pepper plant, known as the long pepper.

Earlier this week, I reported on capsaicin – the spicy chemical in chili peppers – and how this was reported to be effective against some breast cancer subtypes. Rather than capsaicin, researchers found that a chemical in the Indian long pepper (Piper longum), known as piperlongumine (PL), acts to silence a gene that’s overly abundant in cancers.

In some cell experiments, PL killed some types of cancer cells while leaving healthy cells alone. In a mouse xenograft model, PL was shown to be effective at stopping cancer spread. Combined, PL has demonstrated anticancer effects in prostate, breast, lung, colon, lymphoma, leukemia, primary brain tumors, and gastric cancer.

The link between the long pepper and anticancer effects are not new – the medicinal properties and potential of this plant dates back thousands of years in the Ayurveda texts. The plant was also noted in the records from Hippocrates who is well-regarded as the father of medicine.

To shed light o the anecdotal anticancer effects of the long pepper, scientists at the University of Texas, Southwestern investigated the structural and biochemical properties of piperlongumine (PL). Using x-ray crystallography – a technique that reveals the atomic and molecular structure of compounds – the team analyzed what happens to PL after it enters the body.

They showed after hydrolysis of PL, the product (hPL) binds at the active site GSTP1 (Glutathione S-transferase pi 1) – a protein that’s overexpressed in cancerous tumors. Binding of hPL at GSTP1’s active site essentially inhibits this protein and may thereby block cancer proliferation.

"We are hopeful that our structure will enable additional drug development efforts to improve the potency of PL for use in a wide range of cancer therapies," said Kenneth Westover, a professor at UT Southwestern, and the study’s senior author. "This research is a spectacular demonstration of the power of x-ray crystallography."

Moreover, the results provide a biological mechanism for what’s been suspected for thousands of years. "This study illustrates the importance of examining and re-examining our theories. In this case we learned something fundamentally new about a 3,000-year-old medical claim using modern science," said Dr. Westover.

The team hopes that in uncovering the x-ray crystal structure of the compound and how it interacts with cancer proteins, further research could lead to new and more effective drug targets. 

Additional sources: UT Southwestern Medical Center

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
OCT 06, 2020
Drug Discovery & Development
New Immunotherapy Drug Effective Against Lung Cancer
OCT 06, 2020
New Immunotherapy Drug Effective Against Lung Cancer
A new study has confirmed that Tecentriq, an immunotherapy drug, improves survival rates among those with newly diagnose ...
OCT 20, 2020
Clinical & Molecular DX
Non-coding RNA As A Barometer For Liver Health
OCT 20, 2020
Non-coding RNA As A Barometer For Liver Health
October is liver cancer awareness month — a month dedicated to educating people about the risk factors and prevent ...
NOV 07, 2020
Cancer
Newly identified biomarker sheds light on antiangiogenic drug responses
NOV 07, 2020
Newly identified biomarker sheds light on antiangiogenic drug responses
A study published last week in the journal EMBO Molecular Medicine provides insight into the molecular mechanisms t ...
NOV 11, 2020
Cell & Molecular Biology
Visualizing a Tumor Suppressor in Action
NOV 11, 2020
Visualizing a Tumor Suppressor in Action
Many types of cells in our bodies are short-lived and need to be replenished. Cell division has to be carefully controll ...
NOV 13, 2020
Cancer
Predictive model assesses risk of adverse side effects for chemotherapy patients
NOV 13, 2020
Predictive model assesses risk of adverse side effects for chemotherapy patients
New research published in npj Systems Biology and Applications showcases a model capable of predicting which patien ...
NOV 26, 2020
Immunology
Armed With ImmunoBait, Red Blood Cells Fight Lung Cancers
NOV 26, 2020
Armed With ImmunoBait, Red Blood Cells Fight Lung Cancers
  There’s a new weapon in the battle against lung cancer metastases: red blood cells equipped with nanopartic ...
Loading Comments...